» Articles » PMID: 35796263

Autoantibody Encephalitis: Presentation, Diagnosis, and Management

Overview
Journal J Clin Neurol
Specialty Neurology
Date 2022 Jul 7
PMID 35796263
Authors
Affiliations
Soon will be listed here.
Abstract

Autoantibody encephalitis causes distinct clinical syndromes involving alterations in mentation, abnormal movements, seizures, psychiatric symptoms, sleep disruption, spasms, and neuromyotonia. The diagnoses can be confirmed by specific antibody tests, although some antibodies may be better detected in spinal fluid and others in serum. Each disorder conveys a risk of certain tumors which may inform diagnosis and be important for treatment. Autoantibodies to receptors and other neuronal membrane proteins are generally thought to be pathogenic and result in loss of function of the targets, so understanding the pharmacology of the receptors may inform our understanding of the syndromes. Patients may be profoundly ill but the syndromes usually respond to immune therapy, although there are differences in the types of immune therapy that are thought to be most effective for the various disorders.

Citing Articles

Viruses and the Brain-A Relationship Prone to Trouble.

Mielcarska M, Rouse B Viruses. 2025; 17(2).

PMID: 40006958 PMC: 11860391. DOI: 10.3390/v17020203.


Brain on Fire: How Brain Infection and Neuroinflammation Drive Worldwide Epilepsy Burden.

Barker-Haliski M, DePaula-Silva A, Pitsch J, Sontheimer H, Hirsch L, Galanopoulou A Epilepsy Curr. 2024; :15357597241242238.

PMID: 39554268 PMC: 11562294. DOI: 10.1177/15357597241242238.


Emerging Biomarkers for the Early Detection of Autoimmune Encephalitis: A Narrative Review.

Bokhari S, Almadhoun M, Khan M, Ahmad S, Awan M, Imran M Cureus. 2024; 16(9):e69038.

PMID: 39391424 PMC: 11464805. DOI: 10.7759/cureus.69038.


VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis.

Monson N, Smith C, Greenberg H, Plumb P, Guzman A, Tse K J Immunol. 2023; 211(9):1332-1339.

PMID: 37712756 PMC: 10593502. DOI: 10.4049/jimmunol.2300156.


Biomarkers in autoimmune diseases of the central nervous system.

Zhang F, Gao X, Liu J, Zhang C Front Immunol. 2023; 14:1111719.

PMID: 37090723 PMC: 10113662. DOI: 10.3389/fimmu.2023.1111719.

References
1.
Husari K, Dubey D . Autoimmune Epilepsy. Neurotherapeutics. 2019; 16(3):685-702. PMC: 6694338. DOI: 10.1007/s13311-019-00750-3. View

2.
Boronat A, Gelfand J, Gresa-Arribas N, Jeong H, Walsh M, Roberts K . Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2012; 73(1):120-8. PMC: 3563722. DOI: 10.1002/ana.23756. View

3.
Schmitt S, Pargeon K, Frechette E, Hirsch L, Dalmau J, Friedman D . Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012; 79(11):1094-100. PMC: 3525298. DOI: 10.1212/WNL.0b013e3182698cd8. View

4.
Probasco J, Benavides D, Ciarallo A, Sanin B, Wabulya A, Bergey G . Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis. Epilepsy Behav Case Rep. 2015; 2:174-8. PMC: 4308031. DOI: 10.1016/j.ebcr.2014.09.005. View

5.
Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View